Wockhardt shares have soared to an 8-year high of Rs 1,212.55, reflecting a remarkable 384% increase since November 10, 2023.

Beta Bionics has launched the integration of its flagship iLet Bionic Pancreas with Abbott’s FreeStyle Libre 3 Plus sensor.

Wyoming’s attorney general, through a settlement with a French multinational pharmaceutical and healthcare company, has guaranteed that Wyoming residents not enrolled in government healthcare ...

The regulatory milestone unlocks access for U.S. care providers and health systems to leading-edge diabetes care technology demonstrated to increase patients' adherence and reduce cost of treatment ...

Biosimilars offer significant cost-saving potential while expanding patient access, particularly in oncology and immunology.

Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known ...

What you need to know More than 500 million people live with diabetes, and around 783 million are expected to have the ...

Type 2 diabetics taking the drug had a lower risk of Alzheimer’s compared to patients on other diabetes drugs Semaglutide is ...

Editorial Note: Forbes Advisor may earn a commission on sales made from partner links on this page, but that doesn't affect our editors' opinions or evaluations. Digital currency has the potential ...

Electric vehicle battery prices are likely to decline by nearly 50% by 2026, driven by technological advancements and falling metal costs. This… Taiwan Semiconductor Manufacturing Company (TSMC) is ...

E*TRADE excels even outside of its $0 commissions, with superb educational resources, portfolio-building tools and a large mutual fund selection. Many, or all, of the products featured on this ...

Now, scientists have made a major breakthrough in developing what has been long called the “holy grail” diabetes treatments — a “smart” insulin that responds in real time to fluctuations in one’s ...